Arcadia Biosciences raises ~$5M via registered direct offering of common stock and warrants

Arcadia Biosciences, Inc.

Sold 4,722,506 shares at $1.05876 per share plus pre-funded warrants to an institutional investor.
Issued investment options for 4,722,506 shares at $0.93376, exercisable immediately for 5 years.
H.C. Wainwright earned a 6% cash fee (est. $300K) plus warrants for 236,125 shares at $1.3235.
Closing occurred August 16, 2022; offering priced at-the-market under Nasdaq rules.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.